Second-Generation (Atypical) Antipsychotics and Metabolic Effects (Record no. 72181)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 00538cam a2200205 4500 |
001 - CONTROL NUMBER | |
control field | CN99665 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 120401t2005 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 11727047 |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | John W. Newcomer |
240 ## - UNIFORM TITLE | |
Uniform title | <a href="CNS Drugs">CNS Drugs</a> |
245 ## - TITLE STATEMENT | |
Title | Second-Generation (Atypical) Antipsychotics and Metabolic Effects |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Date of publication, distribution, etc. | 2005 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1???93- |
500 ## - GENERAL NOTE | |
General note | Serial |
500 ## - GENERAL NOTE | |
General note | 15998156 |
500 ## - GENERAL NOTE | |
General note | 7411340 |
500 ## - GENERAL NOTE | |
General note | 19 |
500 ## - GENERAL NOTE | |
General note | https://doi.org/10.2165/00023210-200519001-00001 |
500 ## - GENERAL NOTE | |
General note | Document_7411340_78691.pdf |
No items available.